Safety and Efficacy of Daclatasvir with Sofosbuvir and Ribavirin in Hepatitis C Virus Infection: A Real World Experience from South Punjab, Pakistan

Waseem Sarwar Malghani, Farooq Mohyud Din Chaudhary, Misbah Shahid, Ahsan Tameez-ud-din, Romaisa Malik, Asma Tameez Ud Din
doi: https://doi.org/10.1101/2021.10.23.21265410

Article usage

Article usage: October 2021 to June 2025

AbstractFullPdf
Oct 2021150430
Nov 2021215555
Dec 202187238
Jan 20224174
Feb 20224009
Mar 20223636
Apr 20224304
May 202222011
Jun 20223405
Jul 20222803
Aug 20222717
Sep 202239018
Oct 20223917
Nov 20222107
Dec 202210012
Jan 202313010
Feb 20231435
Mar 20231807
Apr 20231712
May 20231315
Jun 20231247
Jul 2023411
Aug 202316125
Sep 20231543
Oct 20231006
Nov 202310316
Dec 20231202
Jan 2024814
Feb 2024711
Mar 2024512
Apr 2024602
May 2024701
Jun 20241028
Jul 2024906
Aug 20241248
Sep 20241635
Oct 2024450
Nov 20241108
Dec 2024512
Jan 20257111
Feb 2025906
Mar 20251673
Apr 20251706
May 202513212
Jun 2025932
Back to top
Posted October 25, 2021.
Download PDF
Data/Code
Email
Safety and Efficacy of Daclatasvir with Sofosbuvir and Ribavirin in Hepatitis C Virus Infection: A Real World Experience from South Punjab, Pakistan
Waseem Sarwar Malghani, Farooq Mohyud Din Chaudhary, Misbah Shahid, Ahsan Tameez-ud-din, Romaisa Malik, Asma Tameez Ud Din
medRxiv 2021.10.23.21265410; doi: https://doi.org/10.1101/2021.10.23.21265410
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area